Inactive Instrument
Company Cognetivity Neurosciences Ltd. Canadian Securities Exchange
Stocks
CGN
CA19243C1005
Advanced Medical Equipment & Technology
Business description: Cognetivity Neurosciences Ltd.
Sales by Activity: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
Development of The ICA Platform | - | - | - | - | 45.37K |
Geographical breakdown of sales: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
United Kingdom | - | - | - | - | 45.37K |
Executive Committee: Cognetivity Neurosciences Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 2013-03-31 |
Mark Phillips
CMP | Compliance Officer | 67 | 2017-12-20 |
Composition of the Board of Directors: Cognetivity Neurosciences Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 2016-12-31 |
Mark Phillips
BRD | Director/Board Member | 67 | 2017-12-20 |
Company details: Cognetivity Neurosciences Ltd.
Medical Software & Technology Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.71% | -4.68% | -35.87% | -7.33% | 30.25B | |
| +1.51% | -12.61% | -49.37% | +138.80% | 11.68B | |
| +2.18% | -0.51% | -26.68% | +60.45% | 5.28B | |
| -1.99% | -3.05% | - | - | 2.08B | |
| +2.86% | -10.62% | +45.03% | -34.15% | 1.86B | |
| -3.11% | -1.18% | - | - | 1.72B | |
| -0.08% | -3.34% | -37.93% | - | 1.03B | |
| -2.01% | -3.95% | +36.02% | +103.72% | 865M | |
| -4.53% | -4.82% | -45.89% | -57.53% | 723M | |
| Average | -0.17% | -5.60% | -16.38% | +33.99% | 6.17B | |
| Weighted average by Cap. | +2.37% | -6.65% | -34.04% | +33.60% |
